India Approves Antigen Test To Speed Detection And Management Of SARS-CoV-2 Infections

On July 23, India approved a rapid antigen test to detect SARS-CoV-2 infections. The product is called the Pathocatch COVID-19 Antigen Rapid testing kit, developed and manufactured in India by Mylab Discovery Solutions. The test will be used as part of an integrated program to speed the detection and management of those infected by SARS-CoV-2. The targeted groups of people are the ones who are both capable of transmitting the disease to others and at risk of falling ill with mild to life-threatening symptoms of Covid-19. At present, more than 1.2 million people in India have tested positive for SARS-CoV-2, and the number is rising rapidly. On the day the new test was approved, 45,720 new cases of infection were reported. 

Read full article on Forbes

Originally posted on Forbes (July 28, 2020)

© William A. Haseltine, PhD. All Rights Reserved.